Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating.

A recent development in prolonging the circulation time of drug carriers, such as liposomes and microspheres, has been to minimize their removal by macrophages of the reticuloendothelial system by covering their surface with hydrophilic polymers such as poloxamers, poloxamines and poly(ethyleneglycols). Here we demonstrate that this strategy may not necessarily prolong the circulatory half-life of drug carriers in all animal models. In rats, as opposed to rabbits, a non-phagocytic mechanism in the spleen may be triggered to remove efficiently from the blood drug carriers coated with hydrophilic coatings. Both the size of particle and its hydrophilic coating may act synergistically to trigger this non-phagocytic mechanism. In rats, a remarkable log to log relationship between particle size and spleen uptake was observed for both uncoated and polymeric coated microspheres. The potential implication of these observations in site-specific delivery of drug carriers is discussed.

[1]  S. Moghimi,et al.  Tissue specific opsonins for phagocytic cells and their different affinity for cholesterol‐rich liposomes , 1988, FEBS letters.

[2]  S. Davis,et al.  The effect of poloxamer-407 on liposome stability and targeting to bone marrow: comparison with polystyrene microspheres , 1991 .

[3]  G. Strickland,et al.  Murine malaria: blood clearance and organ sequestration of Plasmodium yoelii-infected erythrocytes , 1982, Infection and immunity.

[4]  R. Armas.  Clinical studies with spleen-specific radiolabeled agents. , 1985, Seminars in nuclear medicine.

[5]  R. Müller,et al.  The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a block copolymer--poloxamine 908. , 1987, Life sciences.

[6]  M. Davies,et al.  The effect of block co-polymers on the uptake of model polystyrene microspheres by Kupffer cells--in vitro and in vivo studies. , 1991, Biochemical Society transactions.

[7]  H M Patel,et al.  Serum opsonins and phagocytosis of saturated and unsaturated phospholipid liposomes. , 1989, Biochimica et biophysica acta.

[8]  V. Torchilin,et al.  Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. , 1991, Biochimica et biophysica acta.

[9]  C. Hunt,et al.  Liposome disposition in vivo. III. Dose and vesicle-size effects. , 1981, Biochimica et biophysica acta.

[10]  N. Van Rooijen,et al.  The effect of elimination of macrophages on the tissue distribution of liposomes containing [3H]methotrexate. , 1984, Biochimica et biophysica acta.

[11]  A. Kappas,et al.  Targeting of heme oxygenase inhibitors to the spleen markedly increases their ability to diminish bilirubin production. , 1989, Pediatrics.

[12]  P. Insel,et al.  Regulation of phospholipase A2 by receptors in MDCK-Dl cells. , 1991, Biochemical Society transactions.

[13]  I. Ariel,et al.  Irradiation of the spleen by the intra‐arterial administration of 90Yttrium microspheres in patients with malignant lymphoma. A preliminary report , 1973, Cancer.

[14]  R. P. Spencer.  Role of radiolabeled erythrocytes in evaluation of splenic function. , 1980, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  T. Saba.  Physiology and physiopathology of the reticuloendothelial system. , 1970, Archives of internal medicine.

[16]  S. Davis,et al.  The organ uptake of intravenously administered colloidal particles can be altered using a non‐ionic surfactant (Poloxamer 338) , 1984, FEBS letters.

[17]  E. Brown,et al.  The role of the spleen in experimental pneumococcal bacteremia. , 1981, The Journal of clinical investigation.